Distinct Sets of Genetic Alterations in Melanoma
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Exposure to ultraviolet light is a major causative factor in melanoma, although the relationship between risk and exposure is complex. We hypothesized that the clinical heterogeneity is explained by genetically distinct types of melanoma with different susceptibility to ultraviolet light. METHODS: We compared genome-wide alterations in the number of copies of DNA and mutational status of BRAF and N-RAS in 126 melanomas from four groups in which the degree of exposure to ultraviolet light differs: 30 melanomas from skin with chronic sun-induced damage and 40 melanomas from skin without such damage; 36 melanomas from palms, soles, and subungual (acral) sites; and 20 mucosal melanomas. RESULTS: We found significant differences in the frequencies of regional changes in the number of copies of DNA and mutation frequencies in BRAF among the four groups of melanomas. Samples could be correctly classified into the four groups with 70 percent accuracy on the basis of the changes in the number of copies of genomic DNA. In two-way comparisons, melanomas arising on skin with signs of chronic sun-induced damage and skin without such signs could be correctly classified with 84 percent accuracy. Acral melanoma could be distinguished from mucosal melanoma with 89 percent accuracy. Eighty-one percent of melanomas on skin without chronic sun-induced damage had mutations in BRAF or N-RAS; the majority of melanomas in the other groups had mutations in neither gene. Melanomas with wild-type BRAF or N-RAS frequently had increases in the number of copies of the genes for cyclin-dependent kinase 4 (CDK4) and cyclin D1 (CCND1), downstream components of the RAS-BRAF pathway. CONCLUSIONS: The genetic alterations identified in melanomas at different sites and with different levels of sun exposure indicate that there are distinct genetic pathways in the development of melanoma and implicate CDK4 and CCND1 as independent oncogenes in melanomas without mutations in BRAF or N-RAS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While these mutations are not UV-signature mutations20, they are more common in sun-exposed skin20–23.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [20]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language for Data Analysis and Graphics
Ihaka, R., & Gentleman, R. (1996) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1996.10474713 · Cited by 11,220
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression Data
Dudoit, S., Fridlyand, J., & Speed, T. P. (2002) · Journal of the American Statistical Association · doi:10.1198/016214502753479248 · Cited by 2,672
Self-citationPinkel, D., Segraves, R., Sudar, D., Clark, S., Poole, I., Kowbel, D., Collins, C., Kuo, W.-L., Chen, C., Zhai, Y., et al. (1998) · Nature Genetics · doi:10.1038/2524 · Cited by 2,240
Self-citationThe histogenesis and biologic behavior of primary human malignant melanomas of the skin.
Clark, W. H., From, L., Bernardino, E. A., & Mihm, M. C. (1969) · PubMed · Cited by 2,112
High frequency of BRAF mutations in nevi
Pollock, P. M., Harper, U. L., Hansen, K. S., Yudt, L. M., Stark, M., Robbins, C. M., Moses, T. Y., Hostetter, G., Wagner, U., Kakareka, J., et al. (2003) · Nature Genetics · doi:10.1038/ng1054 · Cited by 1,730
Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment.
Martin, M. A., Westfall, P. H., & Young, S. S. (1994) · Biometrics · doi:10.2307/2533464 · Cited by 1,699
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
LOWESS: A Program for Smoothing Scatterplots by Robust Locally Weighted Regression
Cleveland, W. S. (1981) · The American Statistician · doi:10.2307/2683591 · Cited by 1,150
Assembly of microarrays for genome-wide measurement of DNA copy number
Snijders, A. M., Nowak, N., Segraves, R., Blackwood, S., Brown, N., Conroy, J., Hamilton, G., Hindle, A. K., Huey, B., Kimura, K., et al. (2001) · Nature Genetics · doi:10.1038/ng754 · Cited by 999
Self-citationDeterminants of BRAF Mutations in Primary Melanomas
Maldonado, J. L., Fridlyand, J., Patel, H., Jain, A. N., Busam, K., Kageshita, T., Ono, T., Albertson, D. G., Pinkel, D., & Bastian, B. C. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg123 · Cited by 664
Self-citationChildhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies
Whiteman, D. C., Whiteman, C. A., & Green, A. C. (2001) · Cancer Causes & Control · doi:10.1023/a:1008980919928 · Cited by 633
Bastian, B. C., LeBoit, P. E., Hamm, H., Bröcker, E.-B., & Pinkel, D. (1998) · PubMed · Cited by 513
Self-citationClassifying Melanocytic Tumors Based on DNA Copy Number Changes
Bastian, B. C., Olshen, A. B., LeBoit, P. E., & Pinkel, D. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63536-5 · Cited by 459
Self-citationMutations and Copy Number Increase of HRAS in Spitz Nevi with Distinctive Histopathological Features
Bastian, B. C., LeBoit, P. E., & Pinkel, D. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64609-3 · Cited by 455
Self-citationMelanocytic Nevi, Solar Keratoses, and Divergent Pathways to Cutaneous Melanoma
Whiteman, D. C., Watt, P., Purdie, D. M., Hughes, M. C., Hayward, N. K., & Green, A. C. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.11.806 · Cited by 449
The classification of malignant melanoma and its histologic reporting
McGovern, V. J., Mihm, M. C., Bailly, C., Booth, J. C., Clark, W. H., Cochran, A. J., Hardy, E. G., Hicks, J. D., Levene, A., Lewis, M. G., et al. (1973) · Cancer · doi:10.1002/1097-0142(197312)32:6<1446::aid-cncr2820320623>3.0.co;2-8 · Cited by 443
Discovery of a novel Raf kinase inhibitor.
Lyons, J. F., Wilhelm, S., Hibner, B., & Bollag, G. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080219 · Cited by 416
Neonatal sunburn and melanoma in mice
Noonan, F. P., Recio, J. A., Takayama, H., Duray, P., Anver, M. R., Rush, W. L., De Fabo, E. C., & Merlino, G. (2001) · Nature · doi:10.1038/35095108 · Cited by 386
Hidden Markov models approach to the analysis of array CGH data
Fridlyand, J., Snijders, A. M., Pinkel, D., Albertson, D. G., & Jain, A. N. (2004) · Journal of Multivariate Analysis · doi:10.1016/j.jmva.2004.02.008 · Cited by 349
Self-citationEpidemiology of melanoma: Clinical dermatology • Review article
Marks, R. (2000) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2000.00693.x · Cited by 341
Cyclin D1 is a candidate oncogene in cutaneous melanoma.
Sauter, E. R., Yeo, U. C., von Stemm, A., Zhu, W., Litwin, S., Tichansky, D. S., Pistritto, G., Nesbit, M., Pinkel, D., Herlyn, M., et al. (2002) · PubMed · Cited by 334
Self-citationPredicting five-year outcome for patients with cutaneous melanoma in a population-based study
Barnhill, R. L., Fine, J. A., Roush, G. C., & Berwick, M. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960801)78:3<427::aid-cncr8>3.0.co;2-g · Cited by 296
Resampling based multiple testing examples and methods for p-value adjustment
Westfall, P. H., & Young, S. S. (1993) · Cited by 279
Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines.
Tsao, H., Zhang, X., Fowlkes, K., & Haluska, F. G. (2000) · PubMed · Cited by 275
Hypomethylation of pericentromeric DNA in breast adenocarcinomas
Narayan, A., Ji, W., Zhang, X.-Y., Marrogi, A., Graff, J. R., Baylin, S. B., & Ehrlich, M. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980911)77:6<833::aid-ijc6>3.0.co;2-v · Cited by 266
Bastian, B. C., Kashani–Sabet, M., Hamm, H., Godfrey, T. E., Moore, D. H., Bröcker, E.-B., LeBoit, P. E., & Pinkel, D. (2000) · PubMed · Cited by 245
Self-citationKelly, J. W., Rivers, J. K., MacLennan, R., Harrison, S., Lewis, A. E., & Tate, B. J. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(94)70005-2 · Cited by 223
Albino, A. P., Nanus, D. M., Mentle, I. R., Cordon‐Cardo, C., McNutt, N. S., Bressler, J., & Andreeff, M. (1989) · PubMed · Cited by 212
Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in scotland
MacKie, R. M., & Aitchison, T. (1982) · British Journal of Cancer · doi:10.1038/bjc.1982.307 · Cited by 203
Cutaneous melanoma: Prognosis and treatment results worldwide
Balch, C. M. (1992) · Seminars in Surgical Oncology · doi:10.1002/ssu.2980080611 · Cited by 182
Malignant melanoma: A unifying concept
Ackerman, A. B. (1980) · Human Pathology · doi:10.1016/s0046-8177(80)80069-4 · Cited by 158
p53 expression and risk factors for cutaneous melanoma: A case-control study
Whiteman, D. C., Parsons, P. G., & Green, A. C. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980911)77:6<843::aid-ijc8>3.0.co;2-u · Cited by 157
The relationship of malignant melanoma, basal and squamous skin cancers to indoor and outdoor work
Beral, V, & Robinson, N. (1981) · British Journal of Cancer · doi:10.1038/bjc.1981.288 · Cited by 155
Is there more than one road to melanoma?
Rivers, J. K. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15649-3 · Cited by 147
Vågerö, D., Ringbäck, G., & Kiviranta, H. (1986) · British Journal of Cancer · doi:10.1038/bjc.1986.80 · Cited by 89
Shaping of tumor and drug-resistant genomes by instability and selection
Snijders, A. M., Fridlyand, J., Mans, D. A., Segraves, R., Jain, A. N., Pinkel, D., & Albertson, D. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206482 · Cited by 82
Self-citationvan Dijk, M., Sprenger, S. H. E., Rombout, P. D. M., Marres, H. A. M., Kaanders, J. H. A. M., Jeuken, J. W. M., & Ruiter, D. J. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10156 · Cited by 64
Cited by
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720
The future of immune checkpoint therapy
Sharma, P., & Allison, J. P. (2015) · Science · doi:10.1126/science.aaa8172 · Cited by 4,878
Determining cell type abundance and expression from bulk tissues with digital cytometry
Newman, A. M., Steen, C. B., Liu, C. L., Gentles, A. J., Chaudhuri, A. A., Scherer, F., Khodadoust, M. S., Esfahani, M. S., Luca, B. A., Steiner, D., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0114-2 · Cited by 4,478
Genomic classification of cutaneous melanoma
Akbani, R., Akdemir, K. C., Aksoy, B. A., Albert, M., Ally, A., Amin, S. B., Arachchi, H., Arora, A., Auman, J. T., Ayala, B., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.044 · Cited by 3,151
“05), consistent with previous studies (Curtin et al., 2005), as well as MDM2 and TERT (p < 0.”
ResultInfluentialSelf-citationInhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
Metadata
- Authors
- Curtin, J. A., Fridlyand, J., Kageshita, T., Patel, H. N., Busam, K. J., Kutzner, H., Cho, K.-H., Aiba, S., Bröcker, E.-B., LeBoit, P. E., Pinkel, D., & Bastian, B. C.
- Affiliations
- University of California, San Francisco (US)
- Kumamoto University Hospital (JP)
- Memorial Sloan Kettering Cancer Center (US)
- Dermatopathologie Friedrichshafen (DE)
- Seoul National University (KR)
- Tohoku University (JP)
- University of Würzburg (DE)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-11-17
- Volume
- 353
- Issue
- 20
- Pages
- 2135-2147
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1989121777
- Cited by
- 2,747
- References
- 38
- Citations by year
- 2026: 54 · 2025: 69 · 2024: 87 · 2023: 91 · 2022: 85 · 2021: 125 · 2020: 165 · 2019: 133 · 2018: 130 · 2017: 164 · 2016: 157 · 2015: 170 · 2014: 197 · 2013: 218 · 2012: 202
- FWCI
- 33.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Funders
- National Cancer Institute (R01CA094963, R33 CA95300, R33CA095300)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- melanoma, UV exposure, acral melanoma, mucosal melanoma, BRAF mutation, NRAS mutation, copy number alterations, CDK4, CCND1, oncogenes, tumor genetic heterogeneity, skin cancer
- MeSH terms
- Adult, Aged, Aged, 80 and over, DNA, Neoplasm, Environmental Exposure, Female, Humans, Male, Melanoma, Middle Aged, Mutation, Nucleic Acid Hybridization, Genes, ras, Risk Factors, Skin Neoplasms, Ultraviolet Rays, Signal Transduction, Genome, Human, Phosphatidylinositol 3-Kinases, Cyclin D1, Mitogen-Activated Protein Kinases, Proto-Oncogene Proteins B-raf, PTEN Phosphohydrolase, Cyclin-Dependent Kinase 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.